Clinical Trials

Toll-Free: 866.320.4573

Call Us Toll Free:

866.223.2273 x1234

S0309, Collecting and Storing Blood and Bone Marrow Samples From Patients With Myeloma, Waldenstrom`s Macroglobulinemia, Amyloidosis, or Monoclonal Gammopathy of Undetermined Significance

Study:

S0309, Myeloma Specimen Repository Protocol, Ancillary

Rationale:

Collecting and storing samples of blood and bone marrow from patients with cancer to study in the laboratory may help doctors find better ways to ways to treat the cancer.

Purpose:

The purpose of this study is to collect and store blood and bone marrow samples from patients with multiple myeloma, smoldering myeloma, Waldenstrom`s macroglobulinemia, amyloidosis, and monoclonal gammopathy of undetermined significance to be tested in the laboratory.

Study Status: Completed

Recruiting:
n/a

Condition Intervention Phase
Lymphoma
Multiple Myeloma and Plasma Cell Neoplasm
Precancerous Condition
Other: biologic sample preservation procedure N/A

Verified by Southwest Oncology Group January, 2013

Sponsored by: Southwest Oncology Group
Information provided by: Southwest Oncology Group
ClinicalTrials.gov identifier: NCT00919139

Study Type: Interventional

Study Design: N/A

Cleveland Clinic Taussig Cancer Center
Cleveland, Ohio 44195
United States

Cleveland Clinic Cancer Center
Independence, Ohio 44131
United States

Cleveland Clinic - Wooster
Wooster, Ohio 44691
United States

Joshua Espstein, DSC., Study Chair

This information is abridged to display results relevant only to Cleveland Clinic. To see complete record visit ClinicalTrials.gov
  Information obtained from ClinicalTrials.gov on
Link to the current ClinicalTrials.gov record.

Cleveland Clinic Mobile Site